product complaints

R&D

As the life sciences field becomes more complex, it is apparent that many aspects of product quality and safety processes are inextricably linked

Events

Partner Content

News

Bristol Myers Squibb now has positive phase 3 data under its belt for celmod mezigdomide, as it waits for an FDA verdict on lead drug iberdomide.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.